Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.
Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H. Urun Y, et al. Among authors: turna h. J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. Epub 2018 Nov 6. J Oncol Pharm Pract. 2019. PMID: 30400750
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.
Abali H, Celik I, Karaca B, Turna H, Kaytan Saglam E, Akman T, Oztop I, Senol Coskun H, Serdar Turhal N, Sezer A, Nayir E, Arican A, Ozkan M, Sevinc A, Demir G, Budakoglu B, Issikdogan A, Engin H, Kilickap S, Coskun U, Oyan B, Harputluoglu H, Er O, Kavgaci H, Elk Ran T. Abali H, et al. Among authors: turna h. J BUON. 2015 Jul-Aug;20(4):1137-41. J BUON. 2015. PMID: 26416068
A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study.
Yalçın Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyılkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E. Yalçın Ş, et al. Among authors: turna h. Onco Targets Ther. 2018 Mar 5;11:1223-1228. doi: 10.2147/OTT.S148917. eCollection 2018. Onco Targets Ther. 2018. PMID: 29551901 Free PMC article.
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study.
Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y. Arzu Yaşar H, et al. Among authors: turna h. J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. Epub 2019 Mar 29. J Oncol Pharm Pract. 2020. PMID: 30924738
Re: Combination of radiotherapy and immunotherapy? Do timing and dose matter?
Ürün Y, Yaşar HA, Turna H, Kılıçkap S, Sezer A, Öksüzoğlu B, Özdemir N, Şendur MN, Abalı H. Ürün Y, et al. Among authors: turna h. J Oncol Pharm Pract. 2019 Dec;25(8):2062-2063. doi: 10.1177/1078155219858176. Epub 2019 Jun 21. J Oncol Pharm Pract. 2019. PMID: 31226917 No abstract available.
Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study.
Yalcin S, Dane F, Oksuzoglu B, Ozdemir NY, Isikdogan A, Ozkan M, Demirag GG, Coskun HS, Karabulut B, Evrensel T, Ustaoglu MA, Ozdemir F, Turna H, Yavuzsen T, Aykan F, Sevinc A, Akbulut H, Yuce D, Hayran M, Kilickap S. Yalcin S, et al. Among authors: turna h. BMC Cancer. 2020 Mar 30;20(1):259. doi: 10.1186/s12885-020-06758-9. BMC Cancer. 2020. PMID: 32228512 Free PMC article. Clinical Trial.
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients.
Peled N, Gillis R, Kilickap S, Froesch P, Orlov S, Filippova E, Demirci U, Christopoulos P, Cicin I, Basal FB, Yilmaz C, Fedor M, Korkmaz T, Paydas S, Gautschi O, Zirtiloglu A, Eralp Y, Cinkir HY, Sezer A, Erman M, Tural D, Turna H, Mazieres J, Dudnik E, Reguart N, Camidge DR, Ng TL, Şenler FÇ, Beypınar İ, Yazılıtaş D, Demirkazık A, Karaoğlu A, Okutur K, Coşkun HŞ, Şendur MAN, Isikdogan A, Cabuk D, Yumuk PF, Yıldız I, Kaplan MA, Özyılkan Ö, Öztop İ, Olmez OF, Aydin K, Aydıner A, Meydan N, Grinberg RD, Roisman LC. Peled N, et al. Among authors: turna h. Lung Cancer. 2020 Oct;148:48-54. doi: 10.1016/j.lungcan.2020.07.022. Epub 2020 Jul 27. Lung Cancer. 2020. PMID: 32799090
Merkel cell carcinoma in Turkey: A multicentric study.
Yildiz F, Demirci U, Küçükarda A, Büyüksimsek M, Sakalar T, Topcu TO, Aslan F, Tufan G, Aydin O, Turna H, Babacan NA, Basoglu T, Kurt B, Yildiz B, Eren T, Demiray AG, Gumusay O, Arslan C, Özdemir N, Urun Y, Baykara M, Turan N, Uysal M, Bilici A, Kavgaci H, Çiçin İ, Kilickap S, Paydas S. Yildiz F, et al. Among authors: turna h. J Cancer Res Ther. 2021 Oct-Dec;17(6):1525-1529. doi: 10.4103/jcrt.JCRT_950_19. J Cancer Res Ther. 2021. PMID: 34916389 Free article.
Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study.
Karadurmus N, Kaplan MA, Sendur MAN, Urun Y, Demirci U, Karaca SB, Goktas Aydin S, Aykan MB, Bilici A, Sezer A, Yilmaz U, Abali H, Yumuk PF, Degirmencioglu S, Demirkazik A, Paydas S, Mirili C, Turna H, Kargi A, Ozdogan M, Guven DC, Ozguroglu M, Kilickap S. Karadurmus N, et al. Among authors: turna h. Curr Med Res Opin. 2024 May 29:1-21. doi: 10.1080/03007995.2024.2359026. Online ahead of print. Curr Med Res Opin. 2024. PMID: 38809230
65 results